| Literature DB >> 32338208 |
Deepaneeta Sarmah1, Aishika Datta1, Swapnil Raut1, Ankan Sarkar1, Birva Shah1, Mariya Bohra1, Upasna Singh1, Priya Jagtap1, Falguni Baidya1, Kiran Kalia1, Xin Wang2, Kunjan R Dave3, Dileep R Yavagal4, Pallab Bhattacharya1.
Abstract
Inflammation is a devastating outcome of cerebrovascular diseases (CVD), namely stroke and atherosclerosis. Numerous studies over the decade have shown that inflammasomes play a role in mediating inflammatory reactions post cellular injury occurring after a stroke or a rupture of an atherosclerotic plaque. In view of this, targeting these inflammatory pathways using different pharmacological therapies may improve outcomes in patients with CVD. Here, we review the mechanisms by which inflammasomes drive the pathogenesis of stroke and atherosclerosis. Also, discussed here are the possible treatment strategies available for inhibiting inflammasomes or their up-stream/down-stream mediators. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Inflammasomes; NLRP; atherosclerosis; inflammation; stroke; therapies
Year: 2020 PMID: 32338208 DOI: 10.2174/1381612826666200427084949
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116